Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-11

Clinical Trial Update: Curcumin (Tumeric) in the Treatment of Irritable Bowel Syndrome: A Randomized-Controlled Trial [Phase 4]

View source ↗

Summary

A Phase 4 randomized controlled trial evaluating curcumin (turmeric) for irritable bowel syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Curcumin (turmeric) (curcumin)

Snippet

Sponsor: Kaiser Permanente | Conditions: Irritable Bowel Syndrome | Phase 4 | Status: COMPLETED